Short Stature Clinical Trial
Official title:
Nutrients and Hormones: Effects in Boys With Disordered Growth - Pilot Study
This study will determine whether adding more calories to the diet helps boys with growth
problems grow better while being treated with Nutropin, a growth hormone that is used to help
children grow taller. The Food and Drug Administration has approved Nutropin for use in
children who are very short. This study will examine whether giving nutritional supplements
in addition to Nutropin can help children grow better than with Nutropin alone.
Boys between 7 and 10 years of age who are very short and below average in weight, but are
otherwise healthy may be eligible for this study. Candidates must qualify for Nutropin
treatments to boost their growth. Boys will be recruited for the study from the Nemours
Children's Clinic in Jacksonville, FL, and from the National Institutes of Health in
Bethesda, MD.
Participants are randomly assigned to one of two treatment groups. One group is observed for
6 months and then receives a Nutropin injection every day for 12 months. The second group
drinks 8 ounces of a high-calorie beverage called Pediasure every day for 6 months and then
receives Nutropin plus Pediasure every day for 12 months. In addition to treatment,
participants undergo the following tests and procedures at the schedule indicated: Baseline,
3, 6, 9, 12, 15 and 18 months
- Clinical examination
- Height measurement
- Body composition assessment: Skin-fold thickness calipers are used in four places on the
body to estimate body fat
- Bioelectric impedance: A small amount of electrical current is used to calculate the
percentage of body fat.
Baseline, 6, 12, and 18 months
- Blood tests
- Bone age x-ray: x-ray of the left hand to measure growth potential
- DEXA (dual energy x-ray absorptiometry) scan: x-ray scan to measure body fat, muscle,
and bone mineral content. The subject lies on a flat table during the scan.
Baseline, 6, and 12 months
- Record of dietary intake: Parents are asked to write down everything the child eats and
drinks for 3 days. Using this record, a dietitian calculates the daily caloric intake.
- Total energy expenditure: This test determines how much energy the child uses. For the
test, the child drinks water labeled with harmless isotopes (heavy oxygen and heavy
hydrogen). For the next 10 days he collects urine in plastic tubes at home. At the end
of the 10 days, the parents bring the urine to the clinic for analysis to determine how
fast the labeled water leaves the body. This information is used to calculate how much
energy the child expends each day.
Participants' weight is measured at 2 and 4 weeks, and then monthly for the remainder of the
18-month study.
We propose a pilot study to examine the role of nutrition and its interaction with growth
hormone (GH) therapy in boys with very short stature who also have delayed bone age
characteristic of constitutional delay of growth and maturation (CDGM). Recent studies have
suggested that insufficient caloric intake may contribute to the pathophysiology of CDGM.
This prompted us to consider whether nutritional intervention may benefit children with
severe short stature who also have CDGM.
To investigate this further, we would like to enroll a total of 20 boys (10-15 boys in
Jacksonville, Florida and 5-10 boys at the NIH, Bethesda, Maryland), ages 7-10 years, who are
otherwise healthy, but have significant short stature (height SDS less than -2.25 = the
current FDA approved indication for the use of GH in idiopathic short stature), delayed bone
age (greater than 12 months below chronologic age), and low BMI and weight-for-height (less
than 25th percentile). Ten boys will be randomized to receive observation for 6 months,
followed by GH therapy for 12 months. Ten boys will be randomized to receive daily liquid
nutritional supplementation for 6 months, followed by combined GH therapy and nutritional
supplementation for 12 months. For all subjects, weight gain will be monitored at 2 weeks, 4
weeks, and then monthly. Height gain and body composition (using skin-fold thickness calipers
and bioelectric impedance analysis) will be assessed every 3 months. Total energy
expenditure, three-day dietary history, bone age, body composition/bone mineral density
(using dual energy X-ray absorptiometry), and laboratory studies (IGF1, IGFBP3, pre-albumin,
transferrin, ghrelin, fasting insulin, glucose, and lipid profile) will be obtained at
baseline and then every 6 months.
We hypothesize that nutritional supplementation alone can lead to small improvements in
linear growth and lean body mass accrual, but when combined with GH therapy, can augment the
anabolic actions of GH, thereby resulting in even greater improvements in linear growth
velocity and lean body mass accrual than GH alone. If the data from this study confirm this
trend, we would then like to proceed with a larger study, appropriately powered based on the
results of this pilot.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02826902 -
Effect of Anesthesia on Quality of Recovery in Patients Undergoing Correctional Tibial Osteotomy - A Randomized Controlled Trial
|
N/A | |
Completed |
NCT00235599 -
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
|
N/A | |
Completed |
NCT01911260 -
Weekly Zinc Chelate Supplementation on Children's Growth
|
Phase 2/Phase 3 | |
Completed |
NCT02137538 -
Aromatase Inhibitor Growth Study: Letrozole vs. Anastrozole
|
Phase 4 | |
Recruiting |
NCT01934270 -
Growth Hormone Secretion Following the Anaerobic Exercise
|
N/A | |
Completed |
NCT00443144 -
D3-GHR Polymorphism and Turner Syndrome
|
N/A | |
Recruiting |
NCT06295341 -
Short Stature and Psychological Well-being
|
||
Recruiting |
NCT05849389 -
Vosoritide for Short Stature in Turner Syndrome
|
Phase 2 | |
Recruiting |
NCT05829252 -
Testing the Feasibility of a Novel Growth Monitoring Smartphone App
|
||
Withdrawn |
NCT03323177 -
Long Term Effects of Nutritional Supplementation on Final Height
|
N/A | |
Completed |
NCT02389803 -
Evaluating the Effect of Nutritional Supplementation on Growth of Short and Lean Adolescents Boys
|
N/A | |
Recruiting |
NCT06294860 -
Biological Age in Children With GH Deficiency Undergoing Hormone Replacement Therapy
|
||
Recruiting |
NCT03123003 -
Bone Age Assessment in Children Using Ultrasound Compared to Wrist X-ray
|
N/A | |
Completed |
NCT03575221 -
Natural History of the Collagen-Related Disorder Osteogenesis Imperfecta and Genotype Phenotype Correlation
|
||
Terminated |
NCT01237041 -
Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children
|
Phase 1/Phase 2 | |
Completed |
NCT04244123 -
Web-based Adherence Information Integrated Nurse-led Monitoring Clinic
|
||
Recruiting |
NCT01901666 -
Assessment Of Gh-Igf-1 Axis In Children With Chronic Myelogenous Leukemia (CML) In Remission
|
Phase 4 | |
Withdrawn |
NCT01970800 -
The Role of Igf-1 Generation Test in Diagnosis and Treatment of Short Stature
|
N/A | |
Completed |
NCT00830141 -
Study of the Molecular Basis in the Pathophysiology of Food Intake and Growth in Children
|
N/A | |
Completed |
NCT00562705 -
Effects of Growth Hormone (GH) Treatment on Eating Regulation
|
N/A |